Delivery to
Bangladesh
All
Search for "medicine products"
Search for "healthcare products"
Search for "beauty products"
Search for "medicine products"
Search for "healthcare products"
Search for "beauty products"
Search for "medicine products"
Search for "healthcare products"
Search for "beauty products"
Search for "healthcare products"
Hello, User
Account & Orders
0
Shop By Category
āĻŦā§āĻ¯āĻŦāĻ¸āĻžāĻ° āĻœāĻ¨ā§āĻ¯ āĻĒāĻžāĻ‡āĻ•āĻžāĻ°āĻŋ āĻĻāĻžāĻŽā§‡ āĻĒāĻŖā§āĻ¯ āĻ•āĻŋāĻ¨āĻ¤ā§‡ āĻ°ā§‡āĻœāĻŋāĻ¸ā§āĻŸā§‡āĻļāĻ¨ āĻ•āĻ°ā§āĻ¨
Register
0 People recently viewed this

Rabix-VC

Injection - (2.5IU/ml)
arogga-brand
Incepta Pharmaceuticals Ltd.
Generic: Rabies Vaccine (Human) BP
ā§ŗ 454.50
ā§ŗ 500
9% OFF

Medicine Overview of Rabix-VC 2.5IU/ml Injection

āĻŦāĻžāĻ‚āĻ˛āĻž
English
Indication
Rabies vaccine is indicated for, prophylactic immunization against rabies, treatment of patients following suspected rabies contact.
Administration
To reconstitute the vaccine, transfer content of supplied diluent into the vial containing freeze-dried preparation. Do not shake. After reconstitution the solution should be homogeneous, clear and free from any particles. Vaccine must be injected immediately after reconstitution and the syringe should be destroyed after use. 1. Method of administration for intramuscular use The 1ml dose of Rabix-vc should be given intramuscularly in the deltoid in adults and in the anterolateral aspect of the thigh muscle in children under 1 year. It should not be injected into the gluteal region. Do not inject intravenously. 2. Method of administration for intradermal...
... Show more
Adult Dose
Intramuscular Active immunisation against rabies Adult: 1 ml for adults: a) Pre-exposure immunization: 1 ml for children and adults. Primary-vaccination: According to the WHO recommendations 1 injection by the intramuscular route on days D0, D7, D21 or D28, followed by a booster dose one year later. Boosters: Thereafter, one injection every 5 years or when the titre is found to be less than 0.5 IU/ml b) Post-exposure immunization: Vaccination of non-immunized subjects: Intramuscular schedules: One intramuscular (IM) dose comprised of 1 ml. Standard intramuscular (1-1-1-1-1) regimen: Day 0: 1 injection of 1 ml, Day 3: 1 injection of 1 ml,...
... Show more
Child Dose
Intramuscular Child: 1 ml for children: a) Pre-exposure immunization: 1 ml for children and adults. Primary-vaccination: According to the WHO recommendations 1 injection by the intramuscular route on days D0, D7, D21 or D28, followed by a booster dose one year later. Boosters: Thereafter, one injection every 5 years or when the titre is found to be less than 0.5 IU/ml b) Post-exposure immunization: Vaccination of non-immunized subjects: Intramuscular schedules: One intramuscular (IM) dose comprised of 1 ml. Standard intramuscular (1-1-1-1-1) regimen: Day 0: 1 injection of 1 ml, Day 3: 1 injection of 1 ml, Day 7: 1 injection...
... Show more
Contraindication
Pre-exposure Severe fever, febrile infection, acute disease, progressive chronic diseases. Known hypersensitivity reactions to rabies vaccine or any of its components. Post-exposure No contraindication to post-exposure treatment, because rabies is lethal disease, any contraindication to exposure, treatment should be considered carefully before disqualifying an individual for anti-rabies treatment.
... Show more
Mode of Action
Rabies vaccine is an inactivated virus vaccine that is used for active immunisation against rabies. It can be used for pre- and post-exposure immunisation. For post-exposure immunisation, it is often used in conjunction with rabies immunoglobulins as it takes about 7-10 days for the specific antibodies to develop.
Precaution
Possibility of immune complex reaction 2-21 days after booster doses of HDCV (Human diploid cell cultures rabies vaccine); symptoms include arthralgia, arthritis, nausea, malaise, angioedema, fever and vomiting. Caution when used in patients with bleeding disorders, patients on anticoagulant treatment, severely immunocompromised patients. Not to be used in patients with confirmed diagnosis of rabies. Postexposure prophylaxis may be started regardless of the length of time from likely exposure, as long as clinical signs of rabies infection are not present. Pregnancy: The potential risk of administration of rabies vaccine during pregnancy is unknown. Due to the severity of the disease, pregnancy...
... Show more
Side Effect
>10% Injection site pain, soreness, swelling, erythema, itching, burning (30-74%),N/V (5-40%),Abdominal pain (5-40%),Diarrhea (5-40%),Headache (5-40%),Fatigue (5-40%),Localized enlarged lymph nodes sore throat (5-40%),Low grade fever (5-40%),Chills (5-40%),Muscle ache (5-40%),Dizziness (5-40%),Malaise (5-40%)
... Show more
Pregnancy Category Note
Due to the severity of the disease, pregnancy is not considered to be a contra-indication to post-exposure prophylaxis.
Interaction
Concurrent use with immunosuppressants may reduce the efficacy of vaccines.
āĻŦā§āĻ¯āĻŦāĻ¸āĻžāĻ° āĻœāĻ¨ā§āĻ¯ āĻĒāĻžāĻ‡āĻ•āĻžāĻ°āĻŋ āĻĻāĻžāĻŽā§‡ āĻĒāĻŖā§āĻ¯ āĻ•āĻŋāĻ¨āĻ¤ā§‡ āĻ°ā§‡āĻœāĻŋāĻ¸ā§āĻŸā§‡āĻļāĻ¨ āĻ•āĻ°ā§āĻ¨
Register
0 People recently viewed this

Rabix-VC

Injection - (2.5IU/ml)
arogga-brand
Incepta Pharmaceuticals Ltd.
Generic: Rabies Vaccine (Human) BP
ā§ŗ 454.50
ā§ŗ 500
9% OFF

Alternative Brands For Rabix-VC

Sort by:
Relevance
Disclaimer
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.